Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Discovery Lab: USPTO Issues New Patent Supporting AEROSURF Development Program

Discovery Laboratories, Inc. (DSCO: Quote), a specialty biotechnology company, announced the United States Patent and Trademark Office, or USPTO, has issued a Notice of Allowance for a patent entitled "Capillary System With Fluidic Element." The license to this patent will provide the company with additional exclusivity regarding certain proprietary and technical aspects of its capillary aerosol generator technology, a key component of its AEROSURF program.

AEROSURF is an investigational combination drug-device product being developed to deliver Discovery Labs' KL4 surfactant in aerosolized form to premature infants with respiratory distress syndrome. The company plans to initiate its AEROSURF phase 2 clinical program in the fourth quarter of 2013.

Click here to receive FREE breaking news email alerts for Discovery Laboratories Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The South Korean government said Thursday it will increase the budget spending next year and run a wider fiscal deficit than expected to bolster economic growth that faces challenges from slow global recovery and weak domestic demand. Government spending will rise by 5.7 percent to KRW 376 trillion the next year, the finance ministry said in its budget proposals. Stocks saw some volatility following the release of the Federal Reserve's monetary policy announcement on Wednesday but managed to end the day modestly higher. With the upward move, the Dow reached a new record closing high. President Barack Obama sought to emphasize in remarks on Wednesday that the American forces being deployed as part of the fight against the terrorist group ISIS will not have a combat mission.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.